Summary:
Randomized, double-blind, placebo-controlled, parallel-group, 18-month safety and
Efficacy study of Leuco-methylthioninium bis(hydromethanesulfonate) in subjects with
mild Alzheimer’s disease.
Qualified Participants Must:
• Be less than 90 years of age
•
Have been diagnosed with Alzheimer's disease or have noticeable memory loss
•
Have a caregiver willing to accompany subject to visits
Qualified Participants May Receive:
Study medications/placebo, study procedures at no cost as well as compensation for time and travel